ETON Eton Pharmaceutical
- 3.530
- +0.100+2.92%
Eton Pharmaceutical News
Eton Pharmaceutical | 10-Q: Quarterly report
Express News | Eton Pharmaceuticals Inc: Q1 Revenue $8.0 Mln
Express News | Eton Pharmaceuticals Inc: Expects Continued Sales Growth to Result in Positive Operating Cash Flow Throughout Remainder of 2024
Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q1 Revenue $8M, Vs. Street Est of $8M
04:06 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q1 Revenue $8M, vs. Street Est of $8M
Express News | Eton Pharmaceuticals Q1 Basic EPS USD -0.03
Express News | Eton Pharmaceuticals Q1 Net Income USD -811 Thousand
Press Release: Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results -- Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13(th) straight quarter of sequential product sales
Eton Pharmaceuticals 1Q Rev $7.97M >ETON
Eton Pharmaceuticals 1Q Rev $7.97M >ETON
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth• Acquired PKU GOLIKE, launched Nitisinone, and submitted a ne
Eton Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/06/2024 112.77% Craig-Hallum → $8 Initiates Coverage On → Buy 12/11/2023 165.96% HC Wainwright & Co. →
Express News | Eton Pharmaceuticals Inc : Craig-Hallum Initiates Coverage With Buy Rating; Target Price $8
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
DEER PARK, Ill., May 01, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare disease
Express News | Harrow Inc - on April 26, Sold All 1.98 Mln Shares of Eton Pharmaceuticals' Common Stock in Block Trade at Gross Price of $3.00 per Share
Express News | Harrow Inc Reports 0.0% Stake in Eton Pharmaceuticals as of April 26, 2024 Vs 8.1% as of April 12, 2021 - SEC Filing
Express News | Eton Pharmaceuticals Inc - Anticipates 10-Month Review for Potential Approval in Q1 2025
Express News | Eton Pharmaceuticals Inc - Product Has Patent Protection Through 2043
Express News | Eton Pharmaceuticals Inc - Expects Et-400 and Alkindi Sprinkle(®) to Achieve Potential Combined Peak Sales of More Than $50 Mln Annually -
Express News | Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for Et-400 (Hydrocortisone Oral Solution)
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
- Company anticipates 10-month review for potential approval in Q1 2025 -- Eton expects ET-400 and Alkindi Sprinkle to achieve potential combined peak sales of more than $50 million annually -- Produc
RMBS, SANM and WGS Are Among After Hour Movers
Analysis
Price Target
No Data
